Table 4 Tests of measurement equivalence for the SF-36
From: Measurement equivalence of the SF-36 in the canadian multicentre osteoporosis study
Equivalence Hypothesis | SB χ2 | df | Δ SB χ2 | Δdf | CFI | ΔCFI |
|---|---|---|---|---|---|---|
| Â | Caucasian and non-Caucasian females | |||||
Configural | 1067.88 | 32 | - | - | 0.97 | - |
Weak | 1077.48 | 38 | 22.58* | 6 | 0.97 | 0.00 |
Strong | 1212.23 | 46 | 82.05* | 8 | 0.97 | 0.00 |
Complete | 1174.84 | 60 | 21.67 | 14 | 0.97 | 0.00 |
| Â | Caucasian and non-Caucasian males | |||||
Configural | 486.87 | 32 | - | - | 0.97 | - |
Weak | 500.21 | 38 | 10.80 | 6 | 0.97 | 0.00 |
Strong | 561.17 | 46 | 41.58* | 8 | 0.96 | 0.01 |
Complete | 501.75 | 66 | 28.40* | 14 | 0.97 | 0.01 |
| Â | Caucasian females and males | |||||
Configural | 1356.11 | 32 | - | - | 0.97 | - |
Weak | 1355.13 | 38 | 6.74 | 6 | 0.97 | 0.00 |
Strong | 1693.35 | 46 | 364.97* | 8 | 0.97 | 0.00 |
Complete | 1966.86 | 60 | 242.87* | 14 | 0.96 | 0.01 |
| Â | non-Caucasian females and males | |||||
Configural | 79.49 | 32 | - | - | 0.98 | - |
Weak | 83.33 | 38 | 4.69 | 6 | 0.98 | 0.00 |
Strong | 99.81 | 46 | 16.23* | 8 | 0.98 | 0.00 |
Complete | 106.53 | 60 | 10.84 | 14 | 0.98 | 0.00 |